533 related articles for article (PubMed ID: 28122500)
21. Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.
Fletcher SA; Cronin AM; Zeidan AM; Odejide OO; Gore SD; Davidoff AJ; Steensma DP; Abel GA
Cancer; 2016 Apr; 122(8):1209-15. PubMed ID: 26914833
[TBL] [Abstract][Full Text] [Related]
22. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis.
Wachterman MW; Hailpern SM; Keating NL; Kurella Tamura M; O'Hare AM
JAMA Intern Med; 2018 Jun; 178(6):792-799. PubMed ID: 29710217
[TBL] [Abstract][Full Text] [Related]
23. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
[TBL] [Abstract][Full Text] [Related]
24. End-of-life cost and its determinants for cancer patients in urban China: a population-based retrospective study.
Li Z; Pan Z; Zhang L; He R; Jiang S; Xu C; Lu F; Zhang P; Li B
BMJ Open; 2019 Mar; 9(3):e026309. PubMed ID: 30898830
[TBL] [Abstract][Full Text] [Related]
25. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
[TBL] [Abstract][Full Text] [Related]
26. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand.
Anutrakulchai S; Mairiang P; Pongskul C; Thepsuthammarat K; Chan-On C; Thinkhamrop B
BMC Health Serv Res; 2016 Sep; 16(1):528. PubMed ID: 27686066
[TBL] [Abstract][Full Text] [Related]
27. Impact of age on end-of-life care for adult Taiwanese cancer decedents, 2001-2006.
Tang ST; Liu TW; Shyu YI; Huang EW; Koong SL; Hsiao SC
Palliat Med; 2012 Jan; 26(1):80-8. PubMed ID: 21606128
[TBL] [Abstract][Full Text] [Related]
28. Path Analysis on Medical Expenditures of 855 Patients with Chronic Kidney Disease in a Hospital in Beijing.
Liu X; Mao YH; Wang HT; Chen XG; Zhao B; Sun Y
Chin Med J (Engl); 2018 Jan; 131(1):25-31. PubMed ID: 29271376
[TBL] [Abstract][Full Text] [Related]
29. Effect of hospice care on quality indicators of end-of-life care among patients with liver cancer: a national longitudinal population-based study in Taiwan 2000-2011.
Kao YH; Chiang JK
BMC Palliat Care; 2015 Aug; 14():39. PubMed ID: 26286505
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Hemodialysis on Terminal Cancer Patients in Hospices: A Nationwide Retrospective Study in Taiwan.
Kang SC; Lin CC; Chen YC; Wang WS
J Palliat Med; 2019 Feb; 22(2):188-192. PubMed ID: 30601079
[TBL] [Abstract][Full Text] [Related]
31. Disparities in end-of-life care, expenditures, and place of death by health insurance among cancer patients in China: a population-based, retrospective study.
Li Z; Hung P; He R; Tu X; Li X; Xu C; Lu F; Zhang P; Zhang L
BMC Public Health; 2020 Sep; 20(1):1354. PubMed ID: 32887583
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.
Bekelman JE; Halpern SD; Blankart CR; Bynum JP; Cohen J; Fowler R; Kaasa S; Kwietniewski L; Melberg HO; Onwuteaka-Philipsen B; Oosterveld-Vlug M; Pring A; Schreyögg J; Ulrich CM; Verne J; Wunsch H; Emanuel EJ;
JAMA; 2016 Jan; 315(3):272-83. PubMed ID: 26784775
[TBL] [Abstract][Full Text] [Related]
33. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.
Barnato AE; McClellan MB; Kagay CR; Garber AM
Health Serv Res; 2004 Apr; 39(2):363-75. PubMed ID: 15032959
[TBL] [Abstract][Full Text] [Related]
34. The impact of dialysis therapy on older patients with advanced chronic kidney disease: a nationwide population-based study.
Shih CJ; Chen YT; Ou SM; Yang WC; Kuo SC; Tarng DC;
BMC Med; 2014 Oct; 12():169. PubMed ID: 25315422
[TBL] [Abstract][Full Text] [Related]
35. Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
Yusuf AA; Howell BL; Powers CA; St Peter WL
Am J Kidney Dis; 2014 Nov; 64(5):770-80. PubMed ID: 24833203
[TBL] [Abstract][Full Text] [Related]
36. Population-Based Estimates of Health Care Utilization and Expenditures by Adults During the Last 2 Years of Life in Canada's Single-Payer Health System.
Rosella LC; Kornas K; Bornbaum C; Huang A; Watson T; Shuldiner J; Wodchis WP
JAMA Netw Open; 2020 Apr; 3(4):e201917. PubMed ID: 32236531
[TBL] [Abstract][Full Text] [Related]
37. Family Perceptions of Quality of End-of-Life Care for Veterans with Advanced CKD.
Richards CA; Liu CF; Hebert PL; Ersek M; Wachterman MW; Reinke LF; Taylor LL; O'Hare AM
Clin J Am Soc Nephrol; 2019 Sep; 14(9):1324-1335. PubMed ID: 31466952
[TBL] [Abstract][Full Text] [Related]
38. Occupational Variation in End-of-Life Care Intensity.
Hyder JA; Haring RS; Sturgeon D; Gazarian PK; Jiang W; Cooper Z; Lipsitz SR; Prigerson HG; Weissman JS
Am J Hosp Palliat Care; 2018 Mar; 35(3):377-383. PubMed ID: 28571496
[TBL] [Abstract][Full Text] [Related]
39. Utilization and Costs of Health Care in a Kidney Supportive Care Program.
Sowa PM; Purtell L; Hoy WE; Healy HG; Bonner A; Connelly LB
J Palliat Care; 2020 Jul; 35(3):176-184. PubMed ID: 31456473
[TBL] [Abstract][Full Text] [Related]
40. Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort study.
Verberne WR; Dijkers J; Kelder JC; Geers ABM; Jellema WT; Vincent HH; van Delden JJM; Bos WJW
BMC Nephrol; 2018 Aug; 19(1):205. PubMed ID: 30115028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
